$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group

(Hong Kong SAR, China, 1996-2001 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10No. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
C00Lip422584.0101.71787.1102.18661210101.1102.8110.371.8119.7
C01-02Tongue67743850.157.623969.377.51391191511709876.863.758.067.163.2
C03-06Oral cavity56137845.955.918359.569.0507512717113884.861.859.258.752.8
C07-08Salivary gland33018068.277.015083.990.31186355553990.488.274.776.473.0
C11Nasopharynx6593475167.672.2184277.080.727261744109475927080.876.167.564.057.1
C12-13Hypopharynx36033520.424.72550.357.82069941077015.225.525.229.535.6
C15Oesophagus2832229018.923.254229.335.710036469699567733.526.123.026.826.0
C16Stomach5879370931.339.2217030.036.453064010211733195543.043.041.939.332.2
C17Small intestine23912634.841.611336.841.7364241576344.547.553.347.421.5
C18Colon11025581947.660.7520650.361.8754104718893636369964.363.364.062.358.1
C19-21Rectum, anus6192363848.259.2255452.562.650871812382076165262.565.564.761.853.1
C22Liver9256722318.921.5203319.121.81163172022432605152533.825.820.618.513.1
C23-24Gall bladder160175817.522.584318.022.45911021052070235.135.726.624.416.1
C25Pancreas180198914.917.981212.214.79318734860057325.122.623.113.012.5
C30-31Nose/Sinuses28817856.263.911062.674.1505557695782.376.867.158.656.8
C32Larynx1210113057.771.78061.775.13414130944528173.770.678.569.069.2
C33-34Lung211311437516.821.0675617.521.2904183440637490684030.428.925.920.215.5
C37-38Other thoracic organs23013459.864.49660.464.8903831502163.083.974.271.46.6
C40-41Bone25614066.770.211672.575.81533627251575.968.474.762.172.8
C43Melanoma skin26114145.355.712054.463.2553841606768.260.458.255.551.2
C44Other skin2586120778.7100.7137979.4103.9212250371730102396.099.8100.8103.7105.6
C45Mesothelioma503016.018.52035.037.65612161180.717.027.129.40.0
C50Breast101126377.399.81004982.489.73226268915081399129088.590.589.190.493.6
C51-52+C57Vulva, vagina and other female genital organs23223257.669.5352325747571.665.784.669.364.8
C53Cervix2624262470.476.875856342050837583.680.177.473.460.6
C54Corpus uteri1863186379.485.633463140032117793.487.185.976.183.5
C56Ovary1831183163.567.664942227728719684.167.860.650.745.8
C60Penis16116164.183.5161128545275.494.790.687.272.6
C61Prostate3206320655.679.93363521329148668.070.271.082.980.2
C62Testis38338380.890.02374118335494.292.156.793.875.9
C64Kidney91459256.064.932261.068.812819318026115281.864.465.668.450.0
C67Urinary bladder3474262058.476.585455.872.41412525681195131892.985.179.477.367.7
C68Other urinary organs71144043.553.827140.948.3538012622422861.265.868.250.834.4
C69Eye653376.085.33282.387.043149896.80.081.943.697.3
C70-72Brain & nervous system126976540.242.950449.451.758519817520310866.437.931.820.721.1
C73Thyroid223548882.289.6174791.095.3110241930225815499.798.990.583.860.8
C74-75Adrenal gland, other endocrine1599764.067.06274.477.797251714671.190.566.662.222.5
C81Hodgkin lymphoma25715374.278.310487.992.41572724311895.280.276.150.557.2
C82-85+C96Non-Hodgkin lymphoma3318190047.254.9141851.357.771445758582174170.069.160.549.336.0
C90Multiple myeloma79643925.331.735725.030.4359213727925346.753.129.930.421.4
C91Lymphoid leukaemia56131054.660.725155.258.93293751687669.846.539.244.546.0
C92-94Myeloid leukaemia138976630.032.762333.235.253615916628824052.942.630.414.77.4
C95Leukaemia unspecified1417015.617.27131.033.6401911314047.937.819.311.20.0


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Hong Kong SAR, China, 1996-2001 cases followed-up until 2003)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Hong Kong SAR, China, 1996-2001 cases followed-up until 2003)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Hong Kong SAR, China, 1996-2001 cases followed-up until 2003)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Hong Kong SAR, China, 1996-2001 cases followed-up until 2003)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease of breast cancer (Hong Kong SAR, China, 1996-2001)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)